Advanced search×

Redo aortic valve surgery with endovascular control of the internal thoracic artery graft.

J Heart Valve Dis 20(2):175-9 (2011) PMID 21560818

Redo aortic valve surgery (AVS) in patients with patent pedicled internal thoracic artery (ITA) grafts remains a challenging procedure because of the possibility of injury to the grafts and difficulties in optimal myocardial protection. This procedure is associated with a significant mortality and morbidity. Different approaches to myocardial protection and ITA graft dissection and control have been described. An intraoperative technique is proposed that provides endovascular control of the ITA graft, using an angioplasty balloon positioned during cross-clamping.

Version: za2963e q8za6 q8zb9 q8zc3 q8zd5 q8ze7 q8zfe q8zgb

Similar articles you may find interesting…

  1. Predictors of Mortality and Outcomes of Therapy in Low Flow Severe Aortic Stenosis: A PARTNER Trial Analysis.

    Circulation (2013) PMID 23661722

    Low flow is common in severe AS and independently predicts mortality. Survival is improved with TAVR as compared to MM and similar with TAVR and SAVR. A measure of flow (SVI) should be included in the evaluation and therapeutic decision making of patients with severe AS. CLINICAL TRIAL REGISTRATION...
  2. Hybrid Approach in an Acute Type B Aortic Dissection in a Female Patient After Having a Renal Transplant.

    Exp Clin Transplant (2013) PMID 23647485

    This study describes our experiences with a 44-year-old woman who developed acute type B aortic dissection and elected emergency surgery 3 years after a renal transplant. This led to acute ischemia in the right lower extremity. The first stage of surgery was to implant an extra-anato...
  3. The Taussig-Bing anomaly: long-term results.

    Eur J Cardiothorac Surg (2013) PMID 23644700

    Corrective surgery offers excellent survival benefits and encouraging long-term functional outcomes, regardless of the coronary anatomy and associated lesions. Normal biventricular function is preserved in the vast majority of patients, and >3/4 of patients are without cardiac medication. Neverthele...